{"id":2000103237,"date":"2026-02-25T09:30:00","date_gmt":"2026-02-25T07:30:00","guid":{"rendered":"https:\/\/new.igihe.com\/?p=2000103237"},"modified":"2026-02-25T09:06:01","modified_gmt":"2026-02-25T07:06:01","slug":"scientists-in-australia-develop-blood-test-to-predict-head-neck-cancer-relapse","status":"publish","type":"post","link":"https:\/\/new.igihe.com\/english\/scientists-in-australia-develop-blood-test-to-predict-head-neck-cancer-relapse\/","title":{"rendered":"Scientists in Australia develop blood test to predict head, neck cancer relapse"},"content":{"rendered":"\n<p>Researchers analyzed post-surgery blood samples and linked the presence of circulating tumor cells &#8212; cancer cells that have broken away from a tumor and entered the bloodstream &#8212; to increased recurrence odds, said a statement from Australia&#8217;s Centenary Institute on Wednesday.<\/p>\n\n\n\n<p>Around 5,500 Australians face diagnosis annually for head and neck cancer, which affects the lining of the mouth, throat and voice box. While many patients respond well to treatment, a significant number experience relapse, often with limited early warning, said the study published in the European Journal of Surgical Oncology.<\/p>\n\n\n\n<p>Follow-up care relies heavily on scans and clinical exams, which do not always spot early relapse risks, said study co-senior author Jonathan Clark, director of Head and Neck Cancer Research at Australia&#8217;s Chris O&#8217;Brien Lifehouse, in collaboration with Centenary Institute.<\/p>\n\n\n\n<p>&#8220;Our findings suggest that detecting circulating tumor cells could provide additional information to help identify patients who may benefit from closer monitoring after surgery,&#8221; said study lead author Dannel Yeo, laboratory head at the Centenary Institute&#8217;s Center for Cancer Innovations.<\/p>\n\n\n\n<p>The findings add to growing evidence that blood-based biomarkers could play an important role in more personalized cancer care, the researchers said.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Scientists in Australia have developed a simple blood test that detects circulating tumor cells to pinpoint head and neck cancer patients at higher risk of relapse after surgery.<\/p>\n","protected":false},"author":3,"featured_media":2000103238,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[75],"byline":[235],"hashtag":[],"class_list":["post-2000103237","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-homenews","byline-xinhua"],"bylines":[{"id":235,"name":"Xinhua","slug":"xinhua","description":"","image":{"id":0,"url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&f=y&r=g","alt":"Default avatar","title":"Default avatar","caption":"","mime_type":"image\/jpeg","sizes":[]},"user_id":80}],"contributors":[{"id":235,"name":"Xinhua","slug":"xinhua","description":"","image":{"id":0,"url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&f=y&r=g","alt":"Default avatar","title":"Default avatar","caption":"","mime_type":"image\/jpeg","sizes":[]},"user_id":80}],"featured_image":{"id":2000103238,"url":"https:\/\/new.igihe.com\/english\/wp-content\/uploads\/2026\/02\/DTA0271.jpe","alt":"","caption":"","mime_type":"image\/jpeg","width":1078,"height":516,"sizes":{"thumbnail":{"url":"https:\/\/new.igihe.com\/english\/wp-content\/uploads\/2026\/02\/DTA0271.jpe","width":150,"height":72},"medium":{"url":"https:\/\/new.igihe.com\/english\/wp-content\/uploads\/2026\/02\/DTA0271.jpe","width":300,"height":144},"medium_large":{"url":"https:\/\/new.igihe.com\/english\/wp-content\/uploads\/2026\/02\/DTA0271.jpe","width":768,"height":368},"large":{"url":"https:\/\/new.igihe.com\/english\/wp-content\/uploads\/2026\/02\/DTA0271.jpe","width":1024,"height":490},"full":{"url":"https:\/\/new.igihe.com\/english\/wp-content\/uploads\/2026\/02\/DTA0271.jpe","width":1078,"height":516}}},"_links":{"self":[{"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/posts\/2000103237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/comments?post=2000103237"}],"version-history":[{"count":1,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/posts\/2000103237\/revisions"}],"predecessor-version":[{"id":2000103239,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/posts\/2000103237\/revisions\/2000103239"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/media\/2000103238"}],"wp:attachment":[{"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/media?parent=2000103237"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/categories?post=2000103237"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/tags?post=2000103237"},{"taxonomy":"byline","embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/byline?post=2000103237"},{"taxonomy":"hashtag","embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/hashtag?post=2000103237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}